The review discusses the preclinical data available for VEGF supplementation therapy in models of renal disease.
No takes yet. Share an insight, caveat, or question.
Logue et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: